• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

必特螺旋霉素和螺旋霉素在大鼠体内的组织分布

Tissue distribution of bitespiramycin and spiramycin in rats.

作者信息

Shi Xiang-guo, Sun Yu-ming, Zhang Yu-feng, Zhong Da-fang

机构信息

Laboratory of Drug Metabolism and Pharmacokinetics, Shenyang Pharmaceutical University, China.

出版信息

Acta Pharmacol Sin. 2004 Nov;25(11):1396-401.

PMID:15525458
Abstract

AIM

To investigate the tissue distribution of bitespiramycin (BSPM) and spiramycin (SPM) in rats.

METHODS

Liquid chromatographic-mass spectrometric assay was applied for the determination of three major components (isovalerylspiramycins, ISV-SPMs) of BSPM and their major active metabolites (SPMs) in rat tissues and plasma after an oral dose of bitespiramycin, as well as SPMs.

RESULTS

High levels of drug concentrations were observed in most tissues, especially in the liver, stomach, intestine, spleen, lung, womb, and pancreas. BSPM persisted long time in many rat tissues such that the drug concentration in spleen was 69.4 nmol/g at 60 h post-dose and it was still above the minimum inhibitory concentration of many susceptible pathogens. At 2.5 h post-dose, the total concentrations of ISV-SPMs and SPMs achieved in tissues were from 6 to 215 times higher than the corresponding concentrations in plasma. At 2.5 h post-dose, the mean C(t)/C(p) of BSPM appeared to be 2- or 3-fold those of SPM in most tissues. The tissue to plasma concentration ratios following oral dose of BSPM were higher than those of SPM in most tissues. The drug was not detected in brain and testis after a single dose of BSPM and SPM.

CONCLUSION

Both BSPM and SPM penetrate into rat tissues well and BSPM has higher tissue affinity than SPM.

摘要

目的

研究必特螺旋霉素(BSPM)和螺旋霉素(SPM)在大鼠体内的组织分布。

方法

采用液相色谱 - 质谱分析法,测定口服必特螺旋霉素后大鼠组织和血浆中必特螺旋霉素的三种主要成分(异戊酰螺旋霉素,ISV - SPMs)及其主要活性代谢产物(SPMs),以及螺旋霉素。

结果

在大多数组织中观察到较高的药物浓度,尤其是在肝脏、胃、肠道、脾脏、肺、子宫和胰腺中。必特螺旋霉素在许多大鼠组织中持续时间较长,给药后60小时脾脏中的药物浓度为69.4 nmol/g,仍高于许多易感病原体的最低抑菌浓度。给药后2.5小时,组织中ISV - SPMs和SPMs的总浓度比血浆中相应浓度高6至215倍。给药后2.5小时,必特螺旋霉素在大多数组织中的平均C(t)/C(p)似乎是螺旋霉素的2至3倍。口服必特螺旋霉素后,大多数组织中药物的组织与血浆浓度比高于螺旋霉素。单次给药必特螺旋霉素和螺旋霉素后,在脑和睾丸中未检测到药物。

结论

必特螺旋霉素和螺旋霉素均能很好地渗透到大鼠组织中,且必特螺旋霉素比螺旋霉素具有更高的组织亲和力。

相似文献

1
Tissue distribution of bitespiramycin and spiramycin in rats.必特螺旋霉素和螺旋霉素在大鼠体内的组织分布
Acta Pharmacol Sin. 2004 Nov;25(11):1396-401.
2
Determination of three major components of bitespiramycin and their major active metabolites in rat plasma by liquid chromatography-ion trap mass spectrometry.采用液相色谱-离子阱质谱法测定大鼠血浆中必特螺旋霉素及其主要活性代谢产物的三种主要成分。
J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Jul 5;791(1-2):45-53. doi: 10.1016/s1570-0232(03)00205-8.
3
Structural identification of bitespiramycin metabolites in rat: a single oral dose study.大鼠体内比泰螺旋霉素代谢产物的结构鉴定:单次口服剂量研究
Xenobiotica. 2005 Apr;35(4):343-58. doi: 10.1080/00498250500087580.
4
Pharmacodynamics and pharmacokinetics of spiramycin and their clinical significance.
Clin Pharmacokinet. 1998 Apr;34(4):303-10. doi: 10.2165/00003088-199834040-00003.
5
Bioavailability of spiramycin and lincomycin after oral administration to fed and fasted pigs.对喂食和禁食猪口服给药后螺旋霉素和林可霉素的生物利用度。
J Vet Pharmacol Ther. 1998 Aug;21(4):251-6. doi: 10.1046/j.1365-2885.1998.00131.x.
6
Leucine improves the component of isovalerylspiramycins for the production of bitespiramycin.亮氨酸可改善用于生产必特螺旋霉素的异戊酰螺旋霉素组分。
Bioprocess Biosyst Eng. 2009 Aug;32(5):641-7. doi: 10.1007/s00449-008-0287-4. Epub 2008 Dec 30.
7
Acid catalysed degradation of some spiramycin derivatives found in the antibiotic bitespiramycin.抗生素必特螺旋霉素中某些螺旋霉素衍生物的酸催化降解
J Pharm Biomed Anal. 2004 Nov 15;36(3):593-600. doi: 10.1016/j.jpba.2004.07.037.
8
Study of Bitespiramycin Distribution in Rats and Cerebrospinal Fluid of Patients by a Sensitive LC-MS/MS Method with Rapid Sample Preparation.采用快速样品制备的灵敏液相色谱-串联质谱法研究大鼠及患者脑脊液中必特螺旋霉素的分布
Molecules. 2024 Feb 28;29(5):1037. doi: 10.3390/molecules29051037.
9
Effect of dose on macrolide distribution in saliva and periodontal tissues of young patients.
J Chemother. 1989 Jul;1(4 Suppl):579-80.
10
[The pharmacokinetic studies on spiramycin and acetylspiramycin in rats].[大鼠体内螺旋霉素和乙酰螺旋霉素的药代动力学研究]
Jpn J Antibiot. 1982 Aug;35(8):1998-2004.

引用本文的文献

1
Efficacy of carrimycin against complex and .卡里霉素对复合物及……的疗效
Microbiol Spectr. 2025 Sep 2;13(9):e0242224. doi: 10.1128/spectrum.02422-24. Epub 2025 Aug 8.
2
Enhancement of carrimycin production in Streptomyces spiramyceticus 54-IA by the reporter-guided selection method with traditional mutagenesis.通过传统诱变的报告基因引导筛选方法提高螺旋链霉菌54-IA中卡里霉素的产量。
BMC Microbiol. 2025 Aug 6;25(1):484. doi: 10.1186/s12866-025-04120-2.
3
Carrimycin, as One of the Drugs in Combination Therapy, for the Treatment of Carbapenem-Resistant Infection.
卡里霉素作为联合治疗药物之一,用于治疗耐碳青霉烯类感染。
Infect Drug Resist. 2024 Aug 19;17:3617-3621. doi: 10.2147/IDR.S468413. eCollection 2024.
4
Efficacy and safety of carrimycin in ten patients with severe pneumonia following solid organ transplantation.卡瑞霉素治疗10例实体器官移植后重症肺炎患者的疗效与安全性。
World J Clin Cases. 2024 May 26;12(15):2542-2550. doi: 10.12998/wjcc.v12.i15.2542.
5
Study of Bitespiramycin Distribution in Rats and Cerebrospinal Fluid of Patients by a Sensitive LC-MS/MS Method with Rapid Sample Preparation.采用快速样品制备的灵敏液相色谱-串联质谱法研究大鼠及患者脑脊液中必特螺旋霉素的分布
Molecules. 2024 Feb 28;29(5):1037. doi: 10.3390/molecules29051037.
6
A Case of Multidrug-Resistant Treated with Carrimycin.1例使用卡里霉素治疗的耐多药病例。
Infect Drug Resist. 2023 Apr 20;16:2365-2369. doi: 10.2147/IDR.S407076. eCollection 2023.
7
Repurposing carrimycin as an antiviral agent against human coronaviruses, including the currently pandemic SARS-CoV-2.将卡里霉素重新用作抗人类冠状病毒的抗病毒药物,包括当前大流行的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)。
Acta Pharm Sin B. 2021 Sep;11(9):2850-2858. doi: 10.1016/j.apsb.2021.02.024. Epub 2021 Mar 11.
8
Engineering of leucine-responsive regulatory protein improves spiramycin and bitespiramycin biosynthesis.工程化亮氨酰-tRNA 合成酶可提高螺旋霉素和二氢螺旋霉素的生物合成。
Microb Cell Fact. 2019 Feb 19;18(1):38. doi: 10.1186/s12934-019-1086-0.
9
Significant reduction of brain cysts caused by Toxoplasma gondii after treatment with spiramycin coadministered with metronidazole in a mouse model of chronic toxoplasmosis.弓形虫感染的慢性模型小鼠经螺旋霉素和甲硝唑联合治疗后,脑部包囊显著减少。
Antimicrob Agents Chemother. 2012 Apr;56(4):1762-8. doi: 10.1128/AAC.05183-11. Epub 2012 Jan 23.
10
Roles of P-glycoprotein, Bcrp, and Mrp2 in biliary excretion of spiramycin in mice.P-糖蛋白、乳腺癌耐药蛋白(Bcrp)和多药耐药相关蛋白2(Mrp2)在小鼠螺旋霉素胆汁排泄中的作用。
Antimicrob Agents Chemother. 2007 Sep;51(9):3230-4. doi: 10.1128/AAC.00082-07. Epub 2007 Jun 18.